Clinical Trials Directory

THERMOCOOLŪ SMARTTOUCH? Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOLŪ SMARTTOUCH? Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • device : THERMOCOOLŪ SMARTTOUCH? Catheter

Phase: Phase 3


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Have had at least 3 atrial fibrillation episodes within 6 months of this study - Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation episodes - 18 years of age or older

External Links

Explore related trials

Contact information

Primary Contact:

Linda Norton, RN, MSN (650)725-5597

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: